ÂÜÀòÂÒÂ×

Tilly (Matilda) Bingham is an accomplished scientist with extensive experience in the pharmaceutical industry, currently serving as CSO/COO at GIO Therapeutics since January 2024. Tilly's notable roles include Executive in Residence at Cumulus Oncology, Executive Committee Member for the European Federation for Medicinal Chemistry and Chemical Biology, and Editor for Progress in Medicinal Chemistry at Elsevier. Previously, Tilly held leadership positions at Concept Life Sciences, including Chief Scientific Officer and Director of the Integrated Drug Discovery Group. Tilly also significantly contributed at Redx Pharma as Head of Research and Operations, focusing on strategic alignment and operational leadership across various research portfolios. Tilly earned a Ph.D. in Organic Chemistry from UCL and a BSc in Chemistry from Imperial College London.